APO Research
Talk to an analyst

APO RESEARCH · REPORT

Third Party Clinical Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Third Party Clinical Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 May 2026195 pages

Choose your research edition.

Industry ResearchThird Party Clinical Testing Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Third Party Clinical Testing Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Third Party Clinical Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Third Party Clinical Testing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Third Party Clinical Testing Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

The global Third Party Clinical Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Third Party Clinical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Third Party Clinical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Third Party Clinical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Third Party Clinical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Third Party Clinical Testing include Labcorp, IQVIA, PAREXEL International Corporation, ICON Plc, Charles River Laboratories, Syneos Health, PPD (Pharmaceutical Product Development), Medpace and WuXi AppTec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Third Party Clinical Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Third Party Clinical Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Third Party Clinical Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Third Party Clinical Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Third Party Clinical Testing Segment by Company

Labcorp

IQVIA

PAREXEL International Corporation

ICON Plc

Charles River Laboratories

Syneos Health

PPD (Pharmaceutical Product Development)

Medpace

WuXi AppTec

Kingmed

Dian Diagnostics

Adicon Clinical Laboratories

Kindstar

DaAn Gene

Berry Genomics

Frontage Holdings

Centre Testing International

Shanghai Labway Clinical Laboratory

Third Party Clinical Testing Segment by Type

Biochemical Tests

Immunity Tests

Routine Blood Tests

Others

Third Party Clinical Testing Segment by Application

Personal

Enterprise

Third Party Clinical Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Third Party Clinical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Third Party Clinical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Third Party Clinical Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Third Party Clinical Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Third Party Clinical Testing industry.

Chapter 3: Detailed analysis of Third Party Clinical Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Third Party Clinical Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Third Party Clinical Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Biochemical Tests Table 3. Key Players of Immunity Tests Table 4. Key Players of Routine Blood Tests Table 3. Key Players of Others Table 4. Global Third Party Clinical Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Personal Table 6. Key Players of Enterprise Table 7. Global Third Party Clinical Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Third Party Clinical Testing Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Third Party Clinical Testing Market Share by Region (2021-2026) Table 10. Global Third Party Clinical Testing Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Third Party Clinical Testing Market Share by Region (2027-2032) Table 12. Third Party Clinical Testing Industry Trends Table 13. Third Party Clinical Testing Industry Drivers Table 14. Third Party Clinical Testing Industry Opportunities and Challenges Table 15. Third Party Clinical Testing Industry Restraints Table 16. Global Third Party Clinical Testing Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Third Party Clinical Testing Revenue Market Share by Company (2021-2026) Table 18. Global Third Party Clinical Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Third Party Clinical Testing Key Company Head Office and Area Served Table 20. Global Third Party Clinical Testing Company, Product Type & Application Table 21. Global Third Party Clinical Testing Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Third Party Clinical Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Third Party Clinical Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Third Party Clinical Testing Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Third Party Clinical Testing Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Third Party Clinical Testing Revenue Market Share by Type (2021-2026) Table 28. Global Third Party Clinical Testing Revenue Market Share by Type (2027-2032) Table 29. Global Third Party Clinical Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Third Party Clinical Testing Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Third Party Clinical Testing Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Third Party Clinical Testing Revenue Market Share by Application (2021-2026) Table 33. Global Third Party Clinical Testing Revenue Market Share by Application (2027-2032) Table 34. Labcorp Company Information Table 35. Labcorp Business Overview Table 36. Labcorp Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Labcorp Third Party Clinical Testing Product Portfolio Table 38. Labcorp Recent Development Table 39. IQVIA Company Information Table 40. IQVIA Business Overview Table 41. IQVIA Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. IQVIA Third Party Clinical Testing Product Portfolio Table 43. IQVIA Recent Development Table 44. PAREXEL International Corporation Company Information Table 45. PAREXEL International Corporation Business Overview Table 46. PAREXEL International Corporation Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. PAREXEL International Corporation Third Party Clinical Testing Product Portfolio Table 48. PAREXEL International Corporation Recent Development Table 49. ICON Plc Company Information Table 50. ICON Plc Business Overview Table 51. ICON Plc Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. ICON Plc Third Party Clinical Testing Product Portfolio Table 53. ICON Plc Recent Development Table 54. Charles River Laboratories Company Information Table 55. Charles River Laboratories Business Overview Table 56. Charles River Laboratories Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Charles River Laboratories Third Party Clinical Testing Product Portfolio Table 58. Charles River Laboratories Recent Development Table 59. Syneos Health Company Information Table 60. Syneos Health Business Overview Table 61. Syneos Health Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Syneos Health Third Party Clinical Testing Product Portfolio Table 63. Syneos Health Recent Development Table 64. PPD (Pharmaceutical Product Development) Company Information Table 65. PPD (Pharmaceutical Product Development) Business Overview Table 66. PPD (Pharmaceutical Product Development) Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. PPD (Pharmaceutical Product Development) Third Party Clinical Testing Product Portfolio Table 68. PPD (Pharmaceutical Product Development) Recent Development Table 69. Medpace Company Information Table 70. Medpace Business Overview Table 71. Medpace Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Medpace Third Party Clinical Testing Product Portfolio Table 73. Medpace Recent Development Table 74. WuXi AppTec Company Information Table 75. WuXi AppTec Business Overview Table 76. WuXi AppTec Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. WuXi AppTec Third Party Clinical Testing Product Portfolio Table 78. WuXi AppTec Recent Development Table 79. Kingmed Company Information Table 80. Kingmed Business Overview Table 81. Kingmed Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Kingmed Third Party Clinical Testing Product Portfolio Table 83. Kingmed Recent Development Table 84. Dian Diagnostics Company Information Table 85. Dian Diagnostics Business Overview Table 86. Dian Diagnostics Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Dian Diagnostics Third Party Clinical Testing Product Portfolio Table 88. Dian Diagnostics Recent Development Table 89. Adicon Clinical Laboratories Company Information Table 90. Adicon Clinical Laboratories Business Overview Table 91. Adicon Clinical Laboratories Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Adicon Clinical Laboratories Third Party Clinical Testing Product Portfolio Table 93. Adicon Clinical Laboratories Recent Development Table 94. Kindstar Company Information Table 95. Kindstar Business Overview Table 96. Kindstar Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Kindstar Third Party Clinical Testing Product Portfolio Table 98. Kindstar Recent Development Table 99. DaAn Gene Company Information Table 100. DaAn Gene Business Overview Table 101. DaAn Gene Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. DaAn Gene Third Party Clinical Testing Product Portfolio Table 103. DaAn Gene Recent Development Table 104. Berry Genomics Company Information Table 105. Berry Genomics Business Overview Table 106. Berry Genomics Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Berry Genomics Third Party Clinical Testing Product Portfolio Table 108. Berry Genomics Recent Development Table 109. Frontage Holdings Company Information Table 110. Frontage Holdings Business Overview Table 111. Frontage Holdings Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Frontage Holdings Third Party Clinical Testing Product Portfolio Table 113. Frontage Holdings Recent Development Table 114. Centre Testing International Company Information Table 115. Centre Testing International Business Overview Table 116. Centre Testing International Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Centre Testing International Third Party Clinical Testing Product Portfolio Table 118. Centre Testing International Recent Development Table 119. Shanghai Labway Clinical Laboratory Company Information Table 120. Shanghai Labway Clinical Laboratory Business Overview Table 121. Shanghai Labway Clinical Laboratory Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Shanghai Labway Clinical Laboratory Third Party Clinical Testing Product Portfolio Table 123. Shanghai Labway Clinical Laboratory Recent Development Table 124. North America Third Party Clinical Testing Market Size by Type (2021-2026) & (US$ Million) Table 125. North America Third Party Clinical Testing Market Size by Type (2027-2032) & (US$ Million) Table 126. North America Third Party Clinical Testing Market Size by Application (2021-2026) & (US$ Million) Table 127. North America Third Party Clinical Testing Market Size by Application (2027-2032) & (US$ Million) Table 128. North America Third Party Clinical Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Third Party Clinical Testing Market Size by Country (2021-2026) Table 130. North America Third Party Clinical Testing Market Size by Country (2027-2032) Table 131. Europe Third Party Clinical Testing Market Size by Type (2021-2026) & (US$ Million) Table 132. Europe Third Party Clinical Testing Market Size by Type (2027-2032) & (US$ Million) Table 133. Europe Third Party Clinical Testing Market Size by Application (2021-2026) & (US$ Million) Table 134. Europe Third Party Clinical Testing Market Size by Application (2027-2032) & (US$ Million) Table 135. Europe Third Party Clinical Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Third Party Clinical Testing Market Size by Country (2021-2026) Table 137. Europe Third Party Clinical Testing Market Size by Country (2027-2032) Table 138. China Third Party Clinical Testing Market Size by Type (2021-2026) & (US$ Million) Table 139. China Third Party Clinical Testing Market Size by Type (2027-2032) & (US$ Million) Table 140. China Third Party Clinical Testing Market Size by Application (2021-2026) & (US$ Million) Table 141. China Third Party Clinical Testing Market Size by Application (2027-2032) & (US$ Million) Table 142. Asia Third Party Clinical Testing Market Size by Type (2021-2026) & (US$ Million) Table 143. Asia Third Party Clinical Testing Market Size by Type (2027-2032) & (US$ Million) Table 144. Asia Third Party Clinical Testing Market Size by Application (2021-2026) & (US$ Million) Table 145. Asia Third Party Clinical Testing Market Size by Application (2027-2032) & (US$ Million) Table 146. Asia Third Party Clinical Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Third Party Clinical Testing Market Size by Country (2021-2026) Table 148. Asia Third Party Clinical Testing Market Size by Country (2027-2032) Table 149. South America, Middle East & Africa Third Party Clinical Testing Market Size by Type (2021-2026) & (US$ Million) Table 150. South America, Middle East & Africa Third Party Clinical Testing Market Size by Type (2027-2032) & (US$ Million) Table 151. South America, Middle East & Africa Third Party Clinical Testing Market Size by Application (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Third Party Clinical Testing Market Size by Application (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Third Party Clinical Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. South America, Middle East & Africa Third Party Clinical Testing Market Size by Country (2021-2026) Table 155. South America, Middle East & Africa Third Party Clinical Testing Market Size by Country (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Third Party Clinical Testing Product Image Figure 2. Global Third Party Clinical Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Third Party Clinical Testing Market Share by Type: 2025 VS 2032 Figure 4. Biochemical Tests Image Figure 5. Immunity Tests Image Figure 6. Routine Blood Tests Image Figure 7. Others Image Figure 8. Global Third Party Clinical Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Third Party Clinical Testing Market Share by Application: 2025 VS 2032 Figure 10. Personal Image Figure 11. Enterprise Image Figure 12. Global Third Party Clinical Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 14. Global Third Party Clinical Testing Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Third Party Clinical Testing Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Third Party Clinical Testing Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Third Party Clinical Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Third Party Clinical Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Third Party Clinical Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Third Party Clinical Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 24. North America Third Party Clinical Testing Market Share by Type (2021-2032) Figure 25. North America Third Party Clinical Testing Market Share by Application (2021-2032) Figure 26. North America Third Party Clinical Testing Market Share by Country (2021-2032) Figure 27. United States Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 28. Canada Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 30. Europe Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 31. Europe Third Party Clinical Testing Market Share by Type (2021-2032) Figure 32. Europe Third Party Clinical Testing Market Share by Application (2021-2032) Figure 33. Europe Third Party Clinical Testing Market Share by Country (2021-2032) Figure 34. Germany Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 35. France Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 37. Italy Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 38. Russia Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 40. China Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 41. China Third Party Clinical Testing Market Share by Type (2021-2032) Figure 42. China Third Party Clinical Testing Market Share by Application (2021-2032) Figure 43. Asia Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 44. Asia Third Party Clinical Testing Market Share by Type (2021-2032) Figure 45. Asia Third Party Clinical Testing Market Share by Application (2021-2032) Figure 46. Asia Third Party Clinical Testing Market Share by Country (2021-2032) Figure 47. Japan Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 51. India Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 52. Australia Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Third Party Clinical Testing Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Third Party Clinical Testing Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Third Party Clinical Testing Market Share by Country (2021-2032) Figure 57. Brazil Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 62. UAE Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 64. Chile Third Party Clinical Testing Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Biochemical Tests
  • Immunity Tests
  • Routine Blood Tests
  • Others
Applications
  • Personal
  • Enterprise
Companies covered
  • Labcorp
  • IQVIA
  • PAREXEL International Corporation
  • ICON Plc
  • Charles River Laboratories
  • Syneos Health
  • PPD (Pharmaceutical Product Development)
  • Medpace
  • WuXi AppTec
  • Kingmed
  • Dian Diagnostics
  • Adicon Clinical Laboratories
  • Kindstar
  • DaAn Gene
  • Berry Genomics
  • Frontage Holdings
  • Centre Testing International
  • Shanghai Labway Clinical Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Third Party Clinical Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Biochemical Tests
  5. 1.2.3 Immunity Tests
  6. 1.2.4 Routine Blood Tests
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Third Party Clinical Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Personal
  11. 1.3.3 Enterprise
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Third Party Clinical Testing Growth Trends by Region
  14. 1.5.1 Global Third Party Clinical Testing Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Third Party Clinical Testing Market Size by Region (2021-2026)
  16. 1.5.3 Third Party Clinical Testing Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Third Party Clinical Testing Market Dynamics
  1. 2.1 Third Party Clinical Testing Industry Trends
  2. 2.2 Third Party Clinical Testing Industry Drivers
  3. 2.3 Third Party Clinical Testing Industry Opportunities and Challenges
  4. 2.4 Third Party Clinical Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Third Party Clinical Testing Revenue by Company (2021-2026)
  2. 3.2 Global Third Party Clinical Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Third Party Clinical Testing Key Company Head office and Area Served
  4. 3.4 Global Third Party Clinical Testing Company, Product Type & Application
  5. 3.5 Global Third Party Clinical Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Third Party Clinical Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Third Party Clinical Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Third Party Clinical Testing Tier 1, Tier 2, and Tier 3
4 Third Party Clinical Testing Market by Type
  1. 4.1 Global Third Party Clinical Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Third Party Clinical Testing Market Size by Type (2021-2032)
  3. 4.3 Global Third Party Clinical Testing Market Size Share by Type (2021-2032)
5 Third Party Clinical Testing Market by Application
  1. 5.1 Global Third Party Clinical Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Third Party Clinical Testing Market Size by Application (2021-2032)
  3. 5.3 Global Third Party Clinical Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Labcorp
  2. 6.1.1 Labcorp Company Information
  3. 6.1.2 Labcorp Business Overview
  4. 6.1.3 Labcorp Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Labcorp Third Party Clinical Testing Product Portfolio
  6. 6.1.5 Labcorp Recent Developments
  7. 6.2 IQVIA
  8. 6.2.1 IQVIA Company Information
  9. 6.2.2 IQVIA Business Overview
  10. 6.2.3 IQVIA Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 IQVIA Third Party Clinical Testing Product Portfolio
  12. 6.2.5 IQVIA Recent Developments
  13. 6.3 PAREXEL International Corporation
  14. 6.3.1 PAREXEL International Corporation Company Information
  15. 6.3.2 PAREXEL International Corporation Business Overview
  16. 6.3.3 PAREXEL International Corporation Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 PAREXEL International Corporation Third Party Clinical Testing Product Portfolio
  18. 6.3.5 PAREXEL International Corporation Recent Developments
  19. 6.4 ICON Plc
  20. 6.4.1 ICON Plc Company Information
  21. 6.4.2 ICON Plc Business Overview
  22. 6.4.3 ICON Plc Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ICON Plc Third Party Clinical Testing Product Portfolio
  24. 6.4.5 ICON Plc Recent Developments
  25. 6.5 Charles River Laboratories
  26. 6.5.1 Charles River Laboratories Company Information
  27. 6.5.2 Charles River Laboratories Business Overview
  28. 6.5.3 Charles River Laboratories Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Charles River Laboratories Third Party Clinical Testing Product Portfolio
  30. 6.5.5 Charles River Laboratories Recent Developments
  31. 6.6 Syneos Health
  32. 6.6.1 Syneos Health Company Information
  33. 6.6.2 Syneos Health Business Overview
  34. 6.6.3 Syneos Health Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Syneos Health Third Party Clinical Testing Product Portfolio
  36. 6.6.5 Syneos Health Recent Developments
  37. 6.7 PPD (Pharmaceutical Product Development)
  38. 6.7.1 PPD (Pharmaceutical Product Development) Company Information
  39. 6.7.2 PPD (Pharmaceutical Product Development) Business Overview
  40. 6.7.3 PPD (Pharmaceutical Product Development) Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 PPD (Pharmaceutical Product Development) Third Party Clinical Testing Product Portfolio
  42. 6.7.5 PPD (Pharmaceutical Product Development) Recent Developments
  43. 6.8 Medpace
  44. 6.8.1 Medpace Company Information
  45. 6.8.2 Medpace Business Overview
  46. 6.8.3 Medpace Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Medpace Third Party Clinical Testing Product Portfolio
  48. 6.8.5 Medpace Recent Developments
  49. 6.9 WuXi AppTec
  50. 6.9.1 WuXi AppTec Company Information
  51. 6.9.2 WuXi AppTec Business Overview
  52. 6.9.3 WuXi AppTec Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 WuXi AppTec Third Party Clinical Testing Product Portfolio
  54. 6.9.5 WuXi AppTec Recent Developments
  55. 6.10 Kingmed
  56. 6.10.1 Kingmed Company Information
  57. 6.10.2 Kingmed Business Overview
  58. 6.10.3 Kingmed Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Kingmed Third Party Clinical Testing Product Portfolio
  60. 6.10.5 Kingmed Recent Developments
  61. 6.11 Dian Diagnostics
  62. 6.11.1 Dian Diagnostics Company Information
  63. 6.11.2 Dian Diagnostics Business Overview
  64. 6.11.3 Dian Diagnostics Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Dian Diagnostics Third Party Clinical Testing Product Portfolio
  66. 6.11.5 Dian Diagnostics Recent Developments
  67. 6.12 Adicon Clinical Laboratories
  68. 6.12.1 Adicon Clinical Laboratories Company Information
  69. 6.12.2 Adicon Clinical Laboratories Business Overview
  70. 6.12.3 Adicon Clinical Laboratories Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Adicon Clinical Laboratories Third Party Clinical Testing Product Portfolio
  72. 6.12.5 Adicon Clinical Laboratories Recent Developments
  73. 6.13 Kindstar
  74. 6.13.1 Kindstar Company Information
  75. 6.13.2 Kindstar Business Overview
  76. 6.13.3 Kindstar Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Kindstar Third Party Clinical Testing Product Portfolio
  78. 6.13.5 Kindstar Recent Developments
  79. 6.14 DaAn Gene
  80. 6.14.1 DaAn Gene Company Information
  81. 6.14.2 DaAn Gene Business Overview
  82. 6.14.3 DaAn Gene Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 DaAn Gene Third Party Clinical Testing Product Portfolio
  84. 6.14.5 DaAn Gene Recent Developments
  85. 6.15 Berry Genomics
  86. 6.15.1 Berry Genomics Company Information
  87. 6.15.2 Berry Genomics Business Overview
  88. 6.15.3 Berry Genomics Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Berry Genomics Third Party Clinical Testing Product Portfolio
  90. 6.15.5 Berry Genomics Recent Developments
  91. 6.16 Frontage Holdings
  92. 6.16.1 Frontage Holdings Company Information
  93. 6.16.2 Frontage Holdings Business Overview
  94. 6.16.3 Frontage Holdings Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Frontage Holdings Third Party Clinical Testing Product Portfolio
  96. 6.16.5 Frontage Holdings Recent Developments
  97. 6.17 Centre Testing International
  98. 6.17.1 Centre Testing International Company Information
  99. 6.17.2 Centre Testing International Business Overview
  100. 6.17.3 Centre Testing International Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Centre Testing International Third Party Clinical Testing Product Portfolio
  102. 6.17.5 Centre Testing International Recent Developments
  103. 6.18 Shanghai Labway Clinical Laboratory
  104. 6.18.1 Shanghai Labway Clinical Laboratory Company Information
  105. 6.18.2 Shanghai Labway Clinical Laboratory Business Overview
  106. 6.18.3 Shanghai Labway Clinical Laboratory Third Party Clinical Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Shanghai Labway Clinical Laboratory Third Party Clinical Testing Product Portfolio
  108. 6.18.5 Shanghai Labway Clinical Laboratory Recent Developments
7 North America
  1. 7.1 North America Third Party Clinical Testing Market Size (2021-2032)
  2. 7.2 North America Third Party Clinical Testing Market Size by Type
  3. 7.2.1 North America Third Party Clinical Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Third Party Clinical Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Third Party Clinical Testing Market Share by Type (2021-2032)
  6. 7.3 North America Third Party Clinical Testing Market Size by Application
  7. 7.3.1 North America Third Party Clinical Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Third Party Clinical Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Third Party Clinical Testing Market Share by Application (2021-2032)
  10. 7.4 North America Third Party Clinical Testing Market Size by Country
  11. 7.4.1 North America Third Party Clinical Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Third Party Clinical Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Third Party Clinical Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Third Party Clinical Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Third Party Clinical Testing Market Size (2021-2032)
  2. 8.2 Europe Third Party Clinical Testing Market Size by Type
  3. 8.2.1 Europe Third Party Clinical Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Third Party Clinical Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Third Party Clinical Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Third Party Clinical Testing Market Size by Application
  7. 8.3.1 Europe Third Party Clinical Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Third Party Clinical Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Third Party Clinical Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Third Party Clinical Testing Market Size by Country
  11. 8.4.1 Europe Third Party Clinical Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Third Party Clinical Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Third Party Clinical Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Third Party Clinical Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Third Party Clinical Testing Market Size (2021-2032)
  2. 9.2 China Third Party Clinical Testing Market Size by Type
  3. 9.2.1 China Third Party Clinical Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Third Party Clinical Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Third Party Clinical Testing Market Share by Type (2021-2032)
  6. 9.3 China Third Party Clinical Testing Market Size by Application
  7. 9.3.1 China Third Party Clinical Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Third Party Clinical Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Third Party Clinical Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Third Party Clinical Testing Market Size (2021-2032)
  2. 10.2 Asia Third Party Clinical Testing Market Size by Type
  3. 10.2.1 Asia Third Party Clinical Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Third Party Clinical Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Third Party Clinical Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Third Party Clinical Testing Market Size by Application
  7. 10.3.1 Asia Third Party Clinical Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Third Party Clinical Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Third Party Clinical Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Third Party Clinical Testing Market Size by Country
  11. 10.4.1 Asia Third Party Clinical Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Third Party Clinical Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Third Party Clinical Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Third Party Clinical Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Third Party Clinical Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Third Party Clinical Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Third Party Clinical Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Third Party Clinical Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Third Party Clinical Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Third Party Clinical Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Third Party Clinical Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Third Party Clinical Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Third Party Clinical Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Third Party Clinical Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Third Party Clinical Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Third Party Clinical Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Third Party Clinical Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Third Party Clinical Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst